The Cultural Influence and Interpretation of Depressive and Anxiety Disorders by Messerschmidt, Joy M
Georgia State University
ScholarWorks @ Georgia State University
Anthropology Honors Theses Department of Anthropology
Spring 5-13-2011
The Cultural Influence and Interpretation of
Depressive and Anxiety Disorders
Joy M. Messerschmidt
Follow this and additional works at: https://scholarworks.gsu.edu/anthro_hontheses
This Thesis is brought to you for free and open access by the Department of Anthropology at ScholarWorks @ Georgia State University. It has been
accepted for inclusion in Anthropology Honors Theses by an authorized administrator of ScholarWorks @ Georgia State University. For more
information, please contact scholarworks@gsu.edu.
Recommended Citation
Messerschmidt, Joy M., "The Cultural Influence and Interpretation of Depressive and Anxiety Disorders." Thesis, Georgia State
University, 2011.
https://scholarworks.gsu.edu/anthro_hontheses/2
 1 
 
THE CULTURAL INFLUENCE AND INTERPRETATION OF DEPRESSIVE AND 
ANXIETY DISORDERS 
 
 
       
 
 
An Honors Thesis 
 
Submitted in Partial Fulfillment of the 
 
Requirements for Graduation with  
 
Undergraduate Research Honors 
 
Georgia State University 
 
2011 
 
by 
 
Joy Messerschmidt 
 
 
 
 
Committee: 
 
 
 
______________________________ 
Dr. Cassandra White, Honors Thesis Director 
 
 
 
______________________________ 
Dr. Robert Sattelmeyer, Honors Program Director 
 
 
 
______________________________ 
Date 
 
 2 
 
THE CULTURAL INFLUENCE AND INTERPRETATION OF DEPRESSIVE AND 
ANXIETY DISORDERS 
by 
 
JOY MESSERSCHMIDT 
 
 
 
Under the Direction of Dr. Cassandra White 
 
 
ABSTRACT 
 
 
The diagnosis and treatment of depressive and anxiety disorders has changed 
rapidly in the past century. Western medicine has produced diagnostic criteria, 
pharmaceuticals, and different therapies, increasing public awareness of these conditions. 
This research investigates the potential and perceived cultural, familial, and political 
influences on anxiety and depressive disorders in the current biomedical system; analyzes 
the effects of this system on the patients within it; and compares the causality, diagnosis, 
and treatment of these conditions cross-culturally. To accomplish these research goals, I 
conducted in-depth interviews with people affected by depression and anxiety in the 
Atlanta area. I will present my analysis of the interview data collected, focusing on the 
extent to which each participants' familial and cultural backgrounds and attitudes towards 
biomedicine affected their choices and experiences with treatment. I also explore the role 
of pharmaceutical advertising and marketing strategies in patients’ perceptions of their 
disorder and treatment options. 
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INTRODUCTION 
Major depressive and clinical anxiety disorders have been recognized as mental 
illnesses for a short period in human history, given that disquiet and dysphoria have been 
present in our species for millennia. This transition from emotional response to biological 
disease was the result of advances in medical technology, shifting cultural perceptions of 
illness and health, and developments in the pharmaceutical industry (Healy 1999, 
Kirmeyer 2001, Kleinman 1981). Depression and anxiety disorders are now relatively 
common, with 16.5% of the United States’ adult population suffering from chronic 
depression and 5.7% from generalized anxiety disorder (NIMH 2005).  
The anthropological community has contributed greatly to the understanding of 
these disorders in the context of the cultural background. Arthur Kleinman (1981, 1985, 
1991) has published extensively on the role of cultural belief systems, social and 
interactional rules, and the ideology of alternative medical systems on the diagnosis, 
treatment, and symptomatology of mood disorders in Asian cultures. His definitive work 
on the concept of the illness experience provides medical professionals with a contextual 
guide to discovering- and utilizing- all aspects of daily life that are highly influential on 
the manifestation, progression, and ultimately, resolution of extended periods of ill 
physical and mental health (Kleinman 1988).  
Emily Martin (2000) discusses the necessity for an anthropological perspective in 
neuroscience. The Western medical system, or biomedicine, has shifted much attention in 
research on depressive and anxiety disorders from the realm of cognitive psychology and 
psychiatry to the chemistry-based neurological field. There are inherent problems, 
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however, with the conceptualization of human emotions, relationships, and personalities 
as strictly biological processes limited to synapses and enzyme exchange (Kirmeyer 
2001, Martin 2000, Pettus 2006). Though this may be all that is testable in a laboratory 
setting, the social scientist knows better. Culture is a primary environmental factor in 
human behavior, and societal norms and standards create a significant difference in the 
amount of variability in the manifestation of the affective disorders categorized today 
(Kirmeyer 2001, Kleinman and Good 1985, Martin 2000).  
The anthropologist cannot be exclusionary, however. Rather, it is essential for all 
branches of the social sciences, psychological and psychiatric communities, and biology 
to instead collaborate to present a larger picture of these disorders (Kleinman and Good 
1985).  Inasmuch as these disorders have begun to be described and medically classified, 
more exceptions, subcategories, and reorganization of conditions has taken place, with 
four, soon-to-be five, revised volumes of the Diagnostic and Statistical Manual for 
Mental Disorders (DSM) available today (Grob 1991, Healy 1999). This reiterates the 
need for collaboration between disciplines, as the anthropological perspective explains, in 
many cases, the variations seen that result in the continual adjustment of diagnostic 
criteria and categorization of mental health disorders. 
Diagnosis of an affective disorder is only part of the illness experience for the 
individual. The progression and, hopefully, resolution of the condition is handled 
differently in every culture; even within cultures, multiple treatment paths are available. 
Consider the Navajo, who have at least four different healing systems with which to treat 
corporal and mental health problems, yet live within the boundaries of contemporary 
American culture as well (Storck et al. 2000). The rapid acceleration of globalization is 
 3 
forcing innumerable cultural systems, both medical and otherwise, to exist in theoretical 
harmony. This can have considerable impact on patients’ willingness to adhere to their 
treatment plan, especially when it conflicts with their own etiological models, concepts of 
health and disease, and attitudes towards acceptable forms of treatment (Kirmeyer 2001). 
To assess the degree of influence that the biomedical model, family history and 
beliefs, and cultural ideals about mental health have exercised on individual illness 
experiences, I conducted ten in-depth interviews with participants who had received a 
medical diagnosis of one or both of these disorders. In this research, I discuss the ways in 
which the culture of families in the United States affects the experience of depressive and 
anxiety disorders, the potential attitudes of patients towards treatment options, and the 
implications these findings hold for further research in the anthropological and 
psychological communities. 
 
THE CULTURAL LENS 
Applying Significance to Cultural Influence 
 
At present, the globally established and politically recognized set of health and 
medical standards is known as the Western medical system, or biomediicine, a system 
categorized by its utilization of randomized controlled trials to achieve the highest 
degrees of validity and reliability in scientific inquiry. This system claims the biomedical 
model of human illness and disease etiology, a model that resulted in the astounding 
successes of antibiotics and vaccinations. Yet this system, due to its dependence on the 
participation and interaction between many different cultural groups, from physicians to 
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research participants, is intrinsically infused with cultural biases and moral beliefs. This 
is especially true for the disciplines of psychiatry and psychology, which rely on reported 
symptoms, interpretation of illness dialogue that is rich in metaphor, and responses that 
are strictly dictated by cultural rules of social conduct (Kirmeyer 2001, Kleinman 
1980,1988).  
The physiobiological processes that occur when a patient experiences an 
emotional response in his or her brain are the same cross-culturally, but the way in which 
that emotional response goes from chemical exchange to illness concept is both deeply 
personal and highly cultural (Kleinman 1980). Addressing the universality of psychiatric 
disorder has allowed psychiatrists and medical anthropologists to assess the degrees of 
cultural influence present in the manifestations and descriptions of mental illness. Arthur 
Kleinman (1980:148-9)`, whose research has focused primarily on psychiatric disorders 
in Chinese culture, found and described three distinct ways that the Chinese tend to deal 
with periods of prolonged depression or anxiety. Unlike many contemporary Westerners, 
who are encouraged and perhaps even comfortable discussing feelings of worry of 
distress with a therapist, the social rules in China, and many other Asian cultures, do not 
necessarily permit overt discussion of personal emotions (Kleinman 1980, Kirmeyer 
2001, Kitanaka 2008). Instead, Kleinman (1980) explains that Chinese patients minimize 
or deny their feelings, dissociate their feelings in a seemingly unrelated action or 
outburst, or report physical symptoms (sleeplessness, headaches, etc) in lieu of emotional 
ones. Though these physical complaints, known as somatization, are symptoms of 
depressive and anxious states in other cultures, the set of symptoms a culture chooses as 
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appropriate and important for medical discussion are based largely on social rules and 
less, perhaps, on the severity of the symptoms.  
 
Linguistic Barriers and the ‘Culture-Bound Syndromes’ 
In a discipline reliant on conversation, language is a critical aspect of psychiatric 
diagnosis, and also highly culturally variable. Aside from the obvious difficulties in 
diagnosing a patient who reports symptoms in an unfamiliar language, even when doctor 
and patient share the same language, subtle differences in word choice and descriptive 
metaphors can make it challenging for the experiences of the patient to be translated into 
an effective diagnosis and path of treatment. This is especially true when considering the 
culture-bound syndromes, or folk illnesses, terms that encompasses a group of mental 
health disorders found almost exclusively in a single culture.  
The trend in psychiatry has been to categorize these disorders under preexisting 
groups, but anthropological research has indicated that though folk illnesses, such as 
susto, nervios and amok, may share symptoms with depressive and anxiety disorders, 
these conditions are culturally distinctive and cannot be lumped with the equally 
culturally influenced disorders decided upon by Western medical institutions (Carr and 
Vitaliano 1985; Kleinman 1980, 1988; Weller et al 2008). A study done by Weller et al. 
(2008) on susto and nervios in Latin American cultures revealed that the onset of susto 
was associated with a specific etiological model, namely, an intensely frightening or 
shocking experience. This experience resulted in the primary symptom of ‘soul loss’, 
accompanied by more traditional symptoms of sleeplessness, loss of interest, and general 
malaise. Weller and colleagues (2008) emphasize the importance of studying culture-
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bound syndromes outside of the confines of specific psychiatric diagnosis, explaining that 
the purpose of such research is to “understand the meaning that folk diagnoses have 
within the community and as possible risk factors for morbidity and mortality,” 
(2008:409).  
Causality and Categorization 
Patient’s etiological beliefs and perceptions of illness symptoms are also 
culturally variable. Kleinman illustrates this fact, and the diagnostic problems associated 
with it, in the introduction to Rethinking Psychiatry (1988) where he presents a 
hypothetical situation in which psychiatrists were asked to assess the mental states of 
Native Americans following the death of a spouse or loved one. Kleinman points out that 
in many Native American cultures, it is common and even expected for the bereaved to 
speak with the deceased for a period after the burial, but in this hypothetical scenario, the 
psychiatrists would assess these as delusions and describe a psychotic state, when 
actually the bereaved were behaving appropriately based on cultural standards (1988:11). 
This hypothetical situation, along with the other previously discussed examples, reveals 
the fundamental problems associated with such a rigid and culturally-sterile set of 
diagnostic criteria as is utilized by many medical professionals today.  
The Diagnostic and Statistical Manual of Mental Disorders (DSM) was created in 
an effort to more closely align mental health research and diagnosis with the biological 
medical standards of testing and classification (Healy 1997, Pettus 2006). The DSM does 
succeed in increasing the reliability of psychological diagnosis, but it fails to increase the 
validity of the categories being utilized. Though psychologists can now consistently 
group individuals with mental illnesses based on shared symptoms, the scientific 
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legitimacy of those groups has not been proven (Healy 1997, Kleinman 1988, Pettus 
2006). In essence, this results in a set of invalid diagnostic criteria that can be 
consistently applied across the general population (Pettus 2006).  
 
A Universal Set of Diagnostic Criteria: The Anthropological Perspective 
This fallacy is well-documented in psychological and ethnographic studies. Storck 
and colleagues (2000), in their work with the Navajo Healing Project, discussed an 
interview with a depressive patient who utilized multiple healing models to cure her 
illness. The patient experienced grief for three months following the death of her father, 
and the DSM-IV categorizes grief as a depressive episode if it persists more than two 
months after the loved one has passed (DSM-IV 1994:327). The patient did experience 
amelioration from her grief after participating in several traditional healing ceremonies, 
but never utilized psychological services and did not experience symptoms prior to her 
father’s death (Storck et al 2000). The benefits of diagnosing this patient as depressed 
due to an arbitrary grieving period limit are few, and the patient improved after seeking 
out her own methods of treatment outside of traditional psychological options.  
Though there is no concrete agreement in Western psychology about the etiology 
of depressive and anxiety disorders, patients whose models differ from those that are 
widely accepted can present diagnostic issues for mental health professionals. Kleinman 
(1980) recalls a young Taiwanese patient who was suffering from anxious feelings, sleep 
loss, nocturnal emissions, and assorted physical complaints. The patient saw several 
Western physicians, a traditional Chinese doctor, a Taoist monk, and finally, Kleinman 
himself (1980:125). From each of these healers, he received a different diagnosis, ranging 
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from neurasthenia to broken kidney. Upon speaking with Kleinman, the patient reveals 
compulsive masturbation and associated guilt, anxious thoughts, and immense frustration 
at being responsible for his own ailments. Though he was referred to a psychiatrist, the 
patient failed to complete his treatment (1980:125). The wide array of the patient’s 
symptoms failed to fit one diagnostic category, and the patient himself was dissatisfied 
with all the diagnoses he received. This case illustrates precisely the role of 
anthropological research in obtaining a well-rounded, multidisciplinary approach to 
appropriate diagnosis and treatment of depressive and anxiety patients.  
  
HISTORICAL CONTEXT 
Background of Psychiatric Biomedicine 
 
Though variations of depressive and anxiety disorders have likely been burdening 
humans for thousands of years, the classification of these conditions as mental illnesses is 
confined to the last century. Even more recent is the development and use of 
antidepressant and anti-anxiety drugs to treat these illnesses. This paradigm shift from 
emotional response to treatable disease reflects a change in cultural attitudes towards 
illness that closely followed the successes of antibiotics and vaccinations (Healy 1999). 
Psychiatric conditions were slowly incorporated into the medical mindset, and 
psychologists eagerly searched for pharmaceutical remedies, hoping for the ‘magic 
bullet’— the penicillin for depression or anxiety (Healy 1999).  
Prior to the conceptualization of these disorders within biomedicine as potentially 
treatable ‘diseases’, psychiatrists and the general public were primarily concerned with 
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severe mental illness— madness or insanity, as they were labeled at the time. The 
accepted treatment for this condition was the institutionalization of the patient in one of 
the oppressive and isolating asylums that had dominated mental healthcare in America 
and Europe for centuries. In the early 1900’s, the United States sent out two censuses 
pertaining specifically to those with severe mental illness in an attempt to discern the 
number of dependent mentally ill patients in the country (Grob 1991). Due to the 
restrains given with the census, researchers were confined to utilizing categories that 
could be easily checked off, with little room for explanation. This created a need for a 
distinctive nosology, and from this point onward, psychiatry began developing, and 
constantly updating, new classification systems for mental illness (Grob 1991).  
As the United States returned from World War II, a major shift was occurring in 
the medical community. Unlike the cure-all tonics from years before, doctors were using 
the scientific method and advances in technology to find specific diseases, and equally 
specific treatments for them. The first volume of the Diagnostic and Statistical Manual 
for Mental Diseases (DSM-I) was published in 1952, the same year the first antipsychotic 
was developed, and contained 106 disorders (Grob 1991, Healy 1999). With each 
subsequent update, new research findings resulted in the addition and subtraction of 
various conditions and potential treatments. Though psychotherapy, electroshock therapy, 
and even neurosurgery were treatment options, the pharmaceutical remedies seemed to 
hold the most potential (Holtzheimer and Mayberg 2011).  
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Discovery and Evolution of Psychotropic Drugs 
Early antidepressants were synthesized from antipsychotic medications devised 
for use with schizophrenics (Healy 1999). Chlorpromazine (Thorazine), the first of these 
antipsychotics, was used to treat the majority of patients in every asylum in the United 
States, and in 1955, Smith, Kline, & French (currently GlaxoSmithKline) made $75 
million from the drug (Healy 1999:46). The prospect of cashing in on the new market for 
psychopharmacology interested other prominent companies, and a new sense of urgency 
was given to the search for novel drugs. Initially, the medical community felt that the 
tranquilizing effects of these antipsychotics were beneficial in schizophrenics, but would 
have little application in treating depression or anxiety (Healy 1999). However, in a 
search for an antihistamine, a variation on Thorazine was synthesized that, upon further 
investigation, seemed to hold potential for treating depressive episodes. Imipramine 
(Tofranil) was a tricyclic antidepressant that was successful in relieving depression 
symptoms in 60% of patients, a statistic that remains the same for antidepressants in use 
today (Healy 1999, Holtzheimer and Mayberg 2011).  
The creation of antidepressants is, in many respects, responsible for the 
conceptualization of depressive illness itself (Healy 1999, Pettus 2006). The psychiatric 
community, though familiar with the symptoms, had not conceived of the condition as a 
disease, but rather the result of environmental, social, and biological factors interacting to 
produce a disordered state (Grob 1991, Healy 1999). Those affected sought treatment 
very infrequently, due to the association between mental illness and full-fledged madness 
that was widely established. Because of this stigma, the percentage of the population 
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suffering from these disorders was not known, and certainly not speculated to the 17% 
that seek diagnosis today (Healy 1999, Pettus 2006). It was only upon the availability of a 
so-called ‘magic bullet’ remedy that psychiatrists began to consider depression as a 
biological disease, because the drugs revealed neurological factors that were previously 
unknown (Healy 1999).  
 
Deinstitutionalization and Efficiency: Capitalism and Capsules 
At the outset, the accessibility of these medications to the general public was 
relatively limited, as trials were conducted primarily in institutional facilities, especially 
in the antipsychotic studies of the 1950’s. Though institutions claimed that the vast 
majority of their residents were schizophrenic, the nosology of psychiatric diagnosis had 
not yet permeated these establishments fully, and many patients were actually suffering 
from mood or panic disorders (Healy 1999). The cost of keeping institutions for the 
mentally ill operational was extremely taxing to the United States’ budget, and Congress 
began investing in the development of psychiatric pharmaceuticals in the late 1950’s 
(Healy 1999). The grant entered the international scientific community through the 
National Institute of Health (NIH) under the guidance of a board consisting of an animal 
behavioral scientist, two pharmacologists, and a physiologist, but only one psychiatrist 
(Healy 1999:95). The ultimate goal was to discover a pharmaceutical treatment that 
would, ideally, allow for the increased functioning and, contiguously, independence of 
the mentally ill population in the United States.  
The intentions behind this movement are noble in some respects; increased 
functionality from those with mental health problems would allow them to more fully 
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participate in society and would likely result in a substantial increase in the patient’s 
quality of life. However, the influence of American capitalism cannot be ignored. The 
market economy relies on efficiency and cost reduction for increased profits that can be 
reinvested into future growth. The United States government, and that of any democratic 
capitalistic government, is run largely like a business, and requires trillions of dollars to 
operate and provide public services. It is also responsible for the safety of its citizens, 
who are additionally customers, and from this, a stark conflict of interest emerges (Pettus 
2006). The initial investment from Congress, by way of its citizen’s taxes, provided the 
psychiatric pharmacological community with funds to carry out the studies that resulted 
in the synthesis and testing of many of today’s pharmaceutical treatment options for 
mental health disorders (Healy 1999).  
The role of the American government in mental healthcare has sustained itself to 
the present day. Though mental healthcare has been deinstitutionalized, patients’ access 
to care and treatment is still largely influenced by the location of government funds and 
support (Healy 1999, Pettus 2006). This involvement will increase substantially when 
President Obama’s proposed health care plan becomes fully enacted and a greater portion 
of the population will be utilizing government-provided health insurance. Medicaid, 
government-provided health insurance for those citizens 65 and older, has already 
followed the prevailing trend in private insurance companies to push primary care 
physicians  (not psychiatrists) towards handling mental health issues and prescribing 
medication in lieu of other, more costly treatment options like psychotherapy (Pettus 
2006). The transfer of mental health patients from specialized therapists and psychiatrists 
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to primary-care physicians has resulted in a massive decrease in patients receiving an 
‘acceptable standard of care’, down to 12.7 percent (Pettus 2006).  
There can be positive effects from this, however. Many psychologists argue that 
this results in more patients seeking treatment that would otherwise not have seen a 
mental health professional (Marcus and Olfson 2010, Pettus 2006). This is reflected in 
current statistical data, showing an increase of over two million patients seeking 
outpatient treatment for depression in the United States in 2007 (Marcus and Olfson 
2010). However, the quantity, not the quality, of the treatment is the focus here. Less 
specific treatment plans and shorter periods of patient-doctor communication may result 
in more people being diagnosed, but the quality of treatment those patients receive is 
decreasing, and the attention of physicians is shifting from those who are seriously 
mentally ill to those with minor disorders and intermittent symptoms (Pettus 2006).  
 The public is becoming increasingly familiar with psychiatric conditions. The 
World Health Organization, Center for Disease Control, and American media outlets 
have been more vocal about the prevalence and signs of these disorders, and more 
recently, advertisements for psychotropic drugs have appeared on cable television. Unlike 
alternative treatments, which cannot be advertised as distinct products in sixty-second 
sound bytes, pills can be marketed towards consumers in between segments of their 
favorite programs. Ads for antidepressants and anti-anxiety medications are also a source 
of information for the public and have been shown to affect perceptions of prevalence, 
lifetime risk, and treatment choice in both mentally ill and healthy members of the 
American population (An et al. 2009, Donohue et al. 2004, Park and Grow 2008).  
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THE ROLE OF ADVERTISING 
 
The Federal Drug Administration (FDA) released guidelines for pharmaceutical 
direct-to-consumer (DTC) advertising in 1997 (Pettus 2006). This resulted in a massive 
surge in pharmaceutical company spending on ads, including those for psychiatric 
medications (Park and Grow 2001). By 2004, $193 million had been spent on DTC ads 
for antidepressants alone (Pettus 2006: 90). Exposure to the television and print ads for 
these drugs has had profound effects on patients’ perceptions of the prevalence of these 
disorders, the susceptibility of the population to them, and the likelihood of a patient to 
choose drug therapy over alternative treatments (An et al. 2009, Donohue et al. 2004, 
Park and Grow 2008).  
Physicians are subject to advertising influence just as much as the general 
population. One study revealed that patients reporting symptoms of depression to their 
primary care physician will specifically request a brand of drug— and are very likely to 
get it (Pettus 2006). Even patients who reported some symptoms, but did not warrant a 
clinical diagnosis, were being prescribed psychotropic drugs (Pettus 2006).         
Television and print are not the only types of marketing utilized by these companies. 
Representatives from drug corporations visit doctors and psychiatrists at their offices, 
often paying for lunch and always leaving free samples. Having access to free pills can 
sway the prescriber’s choice of medication, which may mean a less specialized treatment 
plan for the patient (Pettus 2006). This is especially relevant when considering the last 
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decade’s 150 percent increase in the number of mental health patients soliciting treatment 
from their family doctors (Pettus 2006:44).  
These advertisements are not merely effective at selling drugs. They also serve to 
educate the public about the symptoms of the condition. On television, actors are used to 
illustrate the behaviors and thought patterns of someone with a depressive or anxiety 
disorder, prompting viewers to self-diagnose, and, talk to their doctors about the specified 
medication. However, these ads are short- around a minute- and filled with side effects 
which, in many cases, occupy over half of the total length of the commercial. This time 
restraint leaves very little room for actual information. A recent commercial for the 
antidepressant Cymbalta followed a dreary opening dialogue with a partial list of 
symptoms that only included sadness, loss of interest, and anxiety. These symptoms are 
among those most frequently reported by depression patients, but they are also natural 
responses to many of life’s experiences, and are certainly not sufficient to diagnose an 
individual based on the standards for Major Depressive Disorder in the DSM-IV.  
These advertisements also serve to guide public perception of MDD/GAD 
patients. A commercial for Wellbutrin XL emphasizes repeatedly that this antidepressant 
has a ‘low risk of sexual side effects’, which implies that others don’t. From this, it could 
be inferred that many people on antidepressants suffer from sexual dysfunction or other 
sexual problems. Revealing a personal side effect such as this on cable television could 
result in stigmatization towards individuals taking these medications.  
A study by An and colleagues (2009) revealed that college students which had no 
previous experience with depressive symptoms, either personally or through a friend or 
family member with depression, were more likely to have a positive opinion on 
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antidepressants as a treatment option after viewing DTC ads. This could result in these 
individuals seeking out antidepressants as a rapid fix for the everyday stresses of being a 
student (An et al. 2009). Several studies have shown that patients requesting 
antidepressants from their physicians were far more likely to receive the drugs, even in 
those where the condition was not severe enough to require them (An et al. 2009).  
Park and Grow (2001) discovered a link between exposure to DTC antidepressant 
ads and personal beliefs about the risk and prevalence of depression, especially in men. 
Those who are familiar with DTC antidepressant commercials perceive the prevalence of 
depressive disorders as higher than it actually is (Park and Grow 2001). Males already 
felt their risk of developing depression in their lifetime was much greater than reality 
indicates, with those from the study reporting a perceived 32% risk compared with the 
well-documented 13% risk that has been found (Park and Grow 2001).  One consequence 
of this is a rise in doctor’s visits and prescription use in situations where neither are 
necessarily warranted, meaning higher healthcare costs and exposure to serious side 
effects that could otherwise be avoided. 
Most critically, however, commercials and print ads for psychotropic drugs 
influence the choices of the consumer. Donohue et al. (2004) found that during periods of 
increased spending on DTC ads for antidepressants, there has been a corresponding 
increase in the number of depression patients seeking therapy with psychotropic drugs. 
Though this has positive implications and many individuals are helped by 
antidepressants, there is no room for evaluation or education regarding alternative 
treatments, such as psychotherapy, lifestyle changes, or even ECT, the most successful 
option for severe depression (Holtzheimer and Mayberg 2011). These methods are not 
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products that can be easily advertised, like pills. When this is considered in light of the 
shift of mental healthcare responsibility from a specialist to a primary care physician, it 
becomes apparent why such alternatives are falling by the wayside.  
My research, and that of many others, has indicated that individuals with a 
MDD/GAD in the United States would benefit immensely from more specialized 
treatment plans, greater degree of choice in treatment options, and increased attention 
from medical professionals to the non-biological components of these disorders. 
Accomplishing these goals will require a greater degree of influence from the social 
science community to rebut the reductionist ideals that are gaining ground today (Martin 
2000).  
 
METHODS 
After drafting in-depth interview questions (Appendix) and obtaining the approval 
of the Georgia State Institutional Review Board, I recruited participants for my study 
with flyers posted around the city of Atlanta and by word-of-mouth. To participate, an 
individual must have been over 18 years of age and have received a diagnosis of a major 
depressive disorder or generalized anxiety disorder by a licensed medical professional. 
Qualifications were evaluated on participant’s answers and non-qualified respondents 
were not interviewed or compensated. For those that did qualify, a $25 compensation was 
given following the interview. All participants signed an IRB-approved consent form 
prior to beginning the interview which provided for the recording of the session on my 
personal computer. Pseudonyms were assigned to all participants before the start of the 
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interview. Interview questions were asked as was relevant to the experiences of the 
participant, so interviews varied in length.  
Seven women and three men, ranging from 18 to 54 years of age, were 
interviewed. Three were African-American and seven were Caucasian or Mixed 
European. Six suffered exclusively from depression, one from anxiety, and three 
participants had both. 
RESULTS 
Discussion of Results 
Participant’s responses to the interview topics were varied, but several 
commonalities were observed. The most pervasive theme was that of family history. Nine 
out of ten participants had at least one immediate family member who had been 
diagnosed with a depressive or anxiety disorder. Many individuals cited this as having a 
crucial role in their perceptions of themselves as they began experiencing symptoms. 
Though every participant was experiencing symptoms of their disorder at the time of 
interview, only six were seeking treatment of any kind. Three were using pharmaceutical 
therapy, two were engaging in psychotherapy, and one was utilizing over-the-counter 
supplements and lifestyle changes. Half of those interviewed had previously used one or 
more prescribed medications for treatment, but ceased due to negative side effects, 
inefficacy, or both. Two participants actively refused medication and felt that it was not 
an acceptable treatment option for them. Despite  there being no interview questions 
regarding significant life trauma, seven participants openly mentioned a traumatic event 
or ongoing experience as being relevant to their condition in some way.   
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When considering the role of culture in these disorders, it is especially important 
to examine familial beliefs about mental health. Family acts as a vector to transfer 
cultural information through generations, and nine out of ten participants had an 
immediate family member who was diagnosed with a depressive or anxiety disorder. This 
statistic was the most prominent finding in my research, and leads me to hypothesize that 
although genetics may predispose people to these illnesses, family life and culture play a 
substantial role in treatment seeking, attitudes towards treatment, and the understanding 
of depressive and anxiety disorders. 
 
Familial Behavior Patterns 
This concept has been thoroughly documented and observed by the mental health 
community. Dickstein and colleagues (1999) discuss the role family storytelling holds in 
developing children’s ideas about life experiences, social norms, and ultimately, the 
transmission of symptom sets and depressive behavioral tendencies in a family with at 
least one depressed parent. In their extensive review of  relevant literature, Hozel et al. 
(2011) compiled a list of the most frequently documented risk factors for chronic 
depression, citing family history as the third most reported factor leading to the evolution 
of a depressive episode to a chronic depressive illness. Regarding anxiety disorders, 
Schrock and Woodruff-Borden (2010) explain the dynamic relationship between an 
anxious parent and anxious child, and map the interplay of behavioral patterns and 
authority in the development and understanding of symptoms by the child.  
The ethnographic techniques utilized by anthropologists can yield a more 
complete picture of the critical role family plays in the evolution and acquisition of 
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cultural attitudes towards mental illness. Kleinman (1980:134), in his observations while 
conducting research in Taiwan, explains that the Taiwanese conceive of the family group 
as transcending the lives of the individuals within it. As such, the afflictions, including 
illness, that affect an individual radiate upon the entire family. Emotional expression is 
limited to within the family circle, the setting in which the most important relationships 
will be formed. These cultural beliefs rigidly structure the family dynamic and shape the 
behaviors and social patterns of the children. When applying this information to the 
illness experience of a Taiwanese young adult with a mental health disorder, the critical 
role of family in the potential diagnosis and treatment-seeking behavior is apparent. This 
is well-illustrated by Kleinman’s description of the young Taiwanese man with anxiety 
due to compulsive masturbation mentioned previously.  The patient’s mother followed 
him to all of his doctor’s appointments, meetings with traditional Chinese medicine 
practitioners, and finally, a visit with a monk, in a effort to guide her son to treatment for 
his embarrassing and stigmatized condition. This story reveals the degree of influence 
family beliefs and customs, in addition to relationships, can have on the illness 
experience of a young adult with a depressive or anxiety disorder.  
Today’s intensifying search for cures in the human genome has been inconclusive 
about the precise involvement of heredity and the development of depressive and anxiety 
disorders. A study in 2001 found that only 30% of the variance in the manifestation of 
anxiety disorders was accounted for by genetic factors (Schrock and Woodruff-Borden 
2010). Pettus (2006) points out that the exact genes involved in the hereditary 
transmission of these disorders have not been located due to the immense complexity of 
the task.  
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My own research, as well as that of numerous members of the mental health and 
anthropological communities, has suggested another possible vector- that of family 
behavioral patterns- which may be just as influential in the development of these 
disorders. A parent, child, grandparent, or sibling with the symptoms of a MDD or GAD 
shares their attitudes and beliefs about their condition with the other members of the 
family. The readiness of children to emulate the behaviors of those they love and trust 
may lead to the development of similar behaviors in the child, making the transmission of 
these disorders appear more genetic than actual research has revealed. My findings, and 
those who have published previously on this topic, reflect the fact that behavioral 
tendencies within families can lead to a generational trend in the manifestation of these 
conditions.  
Of the nine participants who had an immediate family member with a depressive 
or anxiety disorder, five were young adults (18-25) that experienced the first onset of 
symptoms in early to mid-childhood. When asked about the prevalence of these disorders 
within their families, and how this affected the experience of their own condition, each 
participant felt that the behaviors and attitudes of their depressed or anxious family 
members had an influence on their treatment choices and understanding of the condition.  
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Discussion of Interviews 
 
Greg, 25, male 
Greg was diagnosed with a depressive disorder in his early teens. Both parents 
and his only sibling, a brother, had also been diagnosed with a depressive or anxiety 
disorder and all were taking medication for the condition. Greg recognized many shared 
behaviors between himself and his parents, such as his pessimistic attitude, something he 
felt contributed to his depressive episodes.  
“Growing up in a house with people that were depressed contributed to me 
becoming depressed. I learned their behaviors, I learned the things that they were doing, 
and I thought those things were normal, and I still struggle with those things. They’ve 
been naturalized, in a of lot ways. I have to make an extra effort to be reflexive in how 
I’m thinking and what I’m doing…  and I see that in my mother, I see that in my father, 
and I definitely see in in my brother, those behaviors are definitely present.”  
 
He explained that he was not surprised to find out that he had depression, but was 
instead surprised by the eagerness of his psychiatrist to prescribe medication.  
“I was very resistant to the idea of taking medication, I recognized that I didn’t 
feel like I was normal, but the idea of taking medication, I felt, made me feel more 
abnormal. Something about the idea of taking medication really bothers me.” 
His therapist and his parents encouraged him to try the antidepressants, and he 
took Effexor, Lexapro, and Wellbutrin, among others, over a period of his teen years. He 
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experienced serious side effects with no noticeable improvement. At one point, he 
decided to secretly stop taking his antidepressants, and had migraines for several months. 
It was only when he complained to his mother and mentioned that he had ceased taking 
the pills that she explained the serious potential for withdrawal complications that are 
associated with certain antidepressants. Greg mentioned that his therapist did not discuss 
potential side effects or withdrawal problems associated with any of the antidepressants.  
His dissatisfaction with Western psychotherapy options led him to his own self-
help treatment method, which included the occasional use of tryptophan, an essential 
amino acid, and rigorous daily exercise. Though he did see some improvement with these 
lifestyle changes, he still experienced episodes of severe depression that limited his 
ability to enact these changes.  
When I asked him how he felt he developed this condition, he said that although 
he was not totally discordant with the biological model, he felt that, most importantly, 
“…it was being raised by people that suffered from the same things. I picked up their 
behaviors, I started to see the world the way they saw it.” In addition, he felt himself 
personally responsible for his depression in some ways, and mentioned several ongoing 
traumatic experiences, including divorce and abuse, as part of his etiological beliefs.   
 
Darrell, 21, male 
Darrell was diagnosed with Generalized Anxiety Disorder and additionally 
suffering from a minor depressive episode. Unlike Greg, Darrell was diagnosed less than 
a year prior to my interview, and had not experimented with multiple treatment options. 
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His father had also been diagnosed, primarily with depression, but Darrell felt that his 
father concealed his disorder well.  
“I’ve just got his traits, that’s it. It didn’t really affect me. Seeing him, it wasn’t 
really noticeable.” 
He also noted that his family never had an open dialogue about the mental health 
conditions that affected them. It was handled as a private matter, and Darrell only 
discussed his symptoms with his psychiatrist. He does not participate in any talk therapy 
on a regular basis. His therapist did, however, mention some side effects and possible 
interactions when taking the drug. Darrell had previously engaged in binge drinking and 
partying on a regular basis, but when his psychiatrist told him to avoid alcohol 
consumption while taking the medication, he complied for the most part. He did feel 
improvement on the pills, saying that prior to beginning pharmaceutical treatment,  
“I’ve been stressed since I can remember in life, just worrying about stuff 
constantly, stuff that may not even matter at all. I think I need to be on [the drugs].” 
Darrell differs from Greg substantially. They suffer the symptoms of two different 
disorders, they have had opposite attitudes towards treatment paths, and they have 
extremely different life histories. However, both men saw a connection between their 
depressed or anxious family members and the development of their own disorders. Greg, 
whose parents were open and participatory in the early diagnosis and treatment process 
for their son, had an extended period to experiment with alternative treatments before 
ultimately rebelling against his parent’s beliefs and choosing his own methods. Darrell, 
however, did not have an open dialogue in his home about mental illness, despite his 
father having the condition for most of his adult life. His behavior patterns reflect this; he 
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spoke only with his psychiatrist, was diagnosed only after he sought medical attention for 
his own reasons, and remained relatively private about the disorder and his treatment with 
family and friends. This mimics the same behavior pattern of his father, illustrating the 
clear influence behavioral choices and family ideas regarding mental health can have on 
the treatment choices of young adult patients. 
 
Alice, 24, female 
Alice received her first diagnosis of depression in early childhood, during family 
therapy sessions. In the years following, she saw several psychiatrists, and was 
additionally diagnosed with GAD. Alice presents an especially interesting case in my 
research because she is adopted. Her adopted father was a physician and also suffered 
from severe depression, which ultimately resulted in him taking his own life. She 
believed her biological parents, though not officially diagnosed, to also suffer from 
depressive and anxiety disorders. Alice was on a variety of antidepressant and anti-
anxiety drugs before ceasing this treatment option and choosing her current method of 
weekly psychotherapy sessions.  
Alice’s adopted parents aligned their mental health beliefs closely with today’s 
Western medical standards, though her mother was generally opposed to psychotropic 
drugs. These beliefs were undoubtedly influenced by her father’s career and his personal 
experiences with depression, and he was Alice’s primary care doctor until his death. 
Following the loss of her father, she was encouraged to begin seeing a psychiatrist, who 
immediately insisted that she be on medication, despite her and her mother’s reservations. 
Her first prescription, unbeknownst to her, was for Risperidone, an antipsychotic used in 
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schizophrenics, though she was not, and has never, experienced any of the symptoms of 
schizophrenia, and would have been extremely young (at 15) for the average age of onset 
of this disorder. The medication did not relieve any of her symptoms and she suffered 
serious side effects, so she researched the pills on the Internet and discovered their 
intended use. When confronted about this, her psychiatrist switched her to an 
antidepressant, followed by another, and finally an anti-anxiety medication, over a one-
year period. She felt no marked improvement on any of the pills, and has not taken any 
since.  
Despite her immersion in Western psychiatry and pharmacology, Alice has 
developed her own etiological model for mental disorders that is a combination of beliefs 
from several perspectives. 
“[Genetics] are important, I think, to a degree. I know a lot of people in my 
(biological) family have struggled with depression… but I don’t see it like “Stop 
Depression!” in the way you stop heart disease, or something. And I don’t think of 
depression as being much of a disease, I think it’s a state of mind you get into from time 
to time.” 
Alice’s adopted mother and biological father share this idea, though to a more 
exaggerated degree. Her biological father doesn’t feel that the disorder warrants any 
treatment, including psychotherapy, and has been disapproving of her continuing to seek 
this treatment method. Her mother, however, has become more supportive, and was 
pleased that Alice was still seeking treatment after discontinuing her pharmaceutical use. 
She explained that her mom noticed the improvement in her mood and behavior after 
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stopping the medication, although, like Greg, she did this without her parent’s 
knowledge, running the risk for withdrawal complications.  
 
MJ, 22, female  
MJ, like Alice, has been diagnosed with depression and anxiety, and has a father 
employed in the medical industry. However, their attitudes towards mental illness and the 
treatment of it differ on many accounts. MJ’s parents have been diagnosed with 
depression and both take antidepressants to alleviate the symptoms. She was diagnosed in 
early childhood and has been on psychotropic medications periodically with differing 
degrees of effectiveness. She is currently taking Zoloft, which is designed to treat the 
symptoms of both disorders, and participating in psychotherapy sessions with positive 
results.  
Though MJ and Alice were both raised in households that subscribed primarily to 
Western psychiatric models, it is important to note that the ideology of their mothers 
differ significantly. MJ’s mother has been diagnosed with depression and is treating it 
with medication, whereas Alice’s mother has never been diagnosed and is opposed to 
psychotropic medications. MJ explained that her mother’s disorder had a notable impact 
on the initial manifestation of her own anxiety symptoms. 
“It kind of sparked for me when my mom was really stressed out. My dad was 
living in Atlanta, and we were in Wisconsin, and she was trying to sell her business. I fed 
off her stress, I guess, and that’s when I started getting the anxiety.” 
MJ explained that her depression symptoms began in early high school. She had 
also been diagnosed with Attention Deficit Disorder (ADD) and dyslexia, and she felt 
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that these conditions inhibited her performance in school. Her difficulties in class 
discouraged her, and she sought relief from the resulting depressive symptoms with her 
psychiatrist. He prescribed Wellbutrin XL but it exacerbated her anxiety, and he later 
switched her to Zoloft, which she uses today with more success. 
MJ added that she felt her experience with mental illness was greatly improved by 
her family’s openness about their own experiences.  
“[My parents] understand. They help me cope with [my anxiety] and help me 
identify it. It was easier, actually, than I think it is for most people, because I understood 
what was going on.” 
This open dialogue, a product of her parents’ conditions and their ideological 
beliefs about the etiology and treatment of those conditions, was highly influential on 
MJ’s illness experience. Her early diagnosis can be attributed to her parents’ awareness 
of mental health issues, making them perceptive, and perhaps even anticipatory, to the 
manifestation of symptoms in their daughter. Parents with alternative concepts of mental 
health who have not directly suffered from a disorder themselves, such as Alice’s mother, 
may be less likely to recognize the symptoms in their children, and thus be less 
participatory in the diagnosis and treatment process. 
 
Stella, 22, female 
Stella has been diagnosed with an anxiety disorder, major depression, and another 
psychological condition that she could not recall, explaining that she did not feel it was a 
valid assessment. She began experiencing symptoms tAt the time of the interview, she 
was experiencing some depression symptoms but her anxiety had largely resolved. Her 
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father had been suffering from severe depression for the majority of his life and was 
treating it effectively with antidepressants for many years. However, Stella did not feel 
that her family was very open about their shared mental health problems, and was only 
made aware of her father’s condition when she asked to see a therapist to alleviate her 
own symptoms.  
“We didn’t really talk about it in my family… It was only after [I asked to see a 
therapist] that he said, ‘Okay, this runs in our family, I’ve been going through this my 
whole life’, and then we started talking about it.” 
Her initial experiences in psychological treatment only utilized psychotherapy, 
but after being referred to a psychiatrist from her therapist was she told she needed 
medication. Her new psychiatrist was not open to discussing other treatment options, and 
her father also encouraged her to try antidepressants, as they had successfully treated his 
condition. She was concerned about some of the serious side effects that she had heard 
about, but her doctor insisted she try the medication and that Stella could call her if she 
experienced suicidal thoughts or anxiety attacks. Reluctantly, she tried three different 
psychotropic drugs and with varying degrees of relief and many adverse side effects, 
including exacerbation of her original symptoms.  
When she asked to change her medication, her psychiatrist insisted that she be 
patient and give the drug a little more time to take effect. Stella waited, but the side 
effects worsened. She was having a very difficult time finding the motivation to complete 
daily tasks, saying, “It was like, I don’t leave the house, I don’t get dressed, I don’t make 
food, I don’t want to talk to anybody, I don’t want to take this [drug] anymore.” Her 
psychiatrist allowed her to cease the treatment, but said that she must take prescription 
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medication or she would be unable to manage her emotions and relationships effectively. 
Stella disagreed, and discontinued seeing that psychiatrist after that time. She has not 
taken medication for her symptoms since then, and explained that she did not believe her 
condition was severe enough to warrant the risk involved with psychotropic drugs.  
Though her father had taken antidepressants for an extended period, her mother 
was critical of her condition. Stella felt that both of her parent’s beliefs were too extreme, 
so she instead adapted her own ideological constructs of her mental health to be 
somewhere in the middle.  
“My mom is the opposite of my dad. She’s like, ‘That’s bullshit, you’re not 
depressed, if you’re sad, do something about it. You don’t need pills,’ and then my dad is 
like, ‘It’s a condition, you have to take pills for it, there’s nothing you can do, you just 
have to take pills for it,’. They’re polar opposites, but I’m neither.” 
Stella is distinct from MJ and Alice in that she was diagnosed in her late teen 
years and pursued treatment independently of her parents. Similarly, Greg, whose parents 
were vocal about their mental health problems, was diagnosed at a young age; comparing 
this to Darrell, whose father kept his own condition private, leaving Darrell to seek 
treatment later in life. My research, though limited in scope, does provide evidence of a 
clear association between parental candor in the discussion of family mental health 
experiences and the early diagnosis and aggressive treatment of these disorders in their 
children.  
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Findings 
The five participants discussed above do possess commonalities- they all had 
parents with a depressive or anxiety disorder in their childhood homes, and all, in turn, 
had experienced onset of these disorders in themselves. However, the variations in 
parent’s behavioral patterns were seen to be highly influential on the recognition and 
treatment of these disorders in their children. Children whose parents were open with 
them about their depression or anxiety were diagnosed at an earlier age than those whose 
parents kept their symptoms private.  
In the sample discussed, there was also a notable parallel between the 
symptomatic parent’s experiences with pharmaceutical therapy and the beliefs of the 
child towards these treatment options. MJ, whose parents both had positive experiences 
with medication, was open to this type of treatment and felt it was effective. Conversely, 
Greg, who observed the negative effects of antidepressants in his parents and experienced 
similar effects in his own treatment, was dissatisfied with pills as a treatment method. 
This trend was also present with Darrell, and somewhat in Stella, who first aligned with 
her father’s perspective, but later found herself in agreement with her mother and ceased 
taking her medication.  
Another point of considerable relevance is the general dissatisfaction of the 
participants with pharmaceutical treatment options. Of the ten total interviewed, seven 
had a negative attitude towards antidepressants or anti-anxiety medications. Out of the 
five highlighted above, only one was currently using prescription drugs with success. All 
of the young adults in the study were offered pharmaceutical therapy as the primary 
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recommended treatment choice by their doctors. Yet this is did not appear to be 
satisfactory, as forty percent of total participants were not currently seeking treatment of 
any kind at the time of interview. This indicates a need for a more case-specific treatment 
plan, where a specialist in mental health considers the full illness experience of the 
patient, as described by Kleinman (1989). This includes further investigation into family 
history, with special attention paid to etiological beliefs, family transparency and 
openness about mental health issues, and familial attitudes about appropriate treatment 
options. Gathering this additional information would allow for the open line of 
communication between patient and practitioner that is crucial to the safe and effective 
management of these disorders.  
The utilization of more specific treatment plans would require the employment of 
a greater variety of treatment choices. Currently, antidepressants are used to treat 
approximately 75% of outpatient depression cases (Marcus and Olfson 2010). 
Intercultural differences in the manifestation, symptomatology, and etiological concepts 
regarding mental illness have been well documented, and the complexity that is 
intrinsically associated with emotional disorders merits increased diversity in treatment 
options (Kleinman 1980,1988; Pettus 2006). The two most dominant forms of treatment 
for depressive and anxiety conditions in biomedicine, psychotherapy and psychotropic 
medication, are only effective at relieving symptoms in 60% of patients (Healy 1999, 
Marcus and Olfson 2010). This further reiterates the need for more research in, and 
application of, alternative treatment plans. 
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THEORETICAL ANALYSIS 
In the Epilogue of Culture and Depression (1985), Kleinman and Good compile a 
set of guidelines for the continued research on affective disorders from a 
multidisciplinary perspective. Of the seven areas that warrant further investigation, two 
were especially fundamental in the formulation of my research model. The authors 
describe a need for more in-depth study of the role that local power dynamics, from 
massive political entities to the rules of family and social interactions, play in the 
experience of depression symptoms and treatment (Kleinman and Good 1985:499). They 
also reiterate the necessity for deeper analysis of the suitability of psychiatric categories 
and diagnostic criteria for the understanding and treatment of affective disorders in other 
cultures (Kleinman and Good 1985: 497-8).  
It is with these principles that I structured my endeavors. I sought to utilize 
Kleinman’s (1988) definitive model of the illness experience as the most appropriate tool 
for gathering significant qualitative data to address these questions from the 
anthropological perspective. The ethnographic techniques he employed in his assessment 
of chronic pain patients are indeed applicable in both the medical and social science 
communities; they enable researchers to acquire a thorough representation of all elements 
of life, from family relationships to employment status, and their effects on the 
symptomatology, progression, and outcome of lifelong health conditions (Kleinman 
1988).  
When engaging in a multidisciplinary study of this nature, it is critical to draw 
influence from several perspectives. Lawrence Kirmeyer (2001) has also analyzed the 
 34 
indubitable place of culture in the development of affective disorders, but through the 
psychological lens. He challenges researchers and practitioners to assess the current 
methods of diagnosis and treatment, and argues that the employment of a more personal, 
investigative diagnostic and treatment process, similar to Kleinman’s (1988) illness 
experience, would result in a dramatic increase in the effectiveness and adherence to 
treatment plans. The responses of my participants clearly indicate a desire for this 
approach in the current mental healthcare system.  
Kirmeyer (2001) also stresses the importance of the structure of the healthcare 
system itself. The present reality for mental health patients in the United States is a 
limited scope of treatment options, often with expensive price tags and serious side 
effects (Healy 1999, Pettus 2006). Our busy lifestyles limit the opportunity for alternative 
treatments that are more longitudinal, and thus time-consuming, such as psychotherapy, 
exercise, or even hobbies and pastimes that provide respite and distraction from the daily 
stress of careers, family, and relationships. The healthcare system is, of course, a cultural 
product, based on the American ideals of efficiency, independence, and cost-
effectiveness (Healy 1999). Yet this cultural product shapes, as Kirmeyer (2001) 
explains, the attitudes of those within it towards available treatment options, prevalence, 
and even the manifestation of a describable symptom set. The limitations this imposes on 
those with affective disorders were echoed in my study, with many participants 
expressing dissatisfaction with the current system and a desire for greater variability in 
their management of the disorder.  
Martin (2000) and Healy (1999) suggest a a significant cultural factor that must 
be given further consideration regarding the continuation of research on this topic. The 
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economic system of contemporary American capitalism was directly responsible for the 
initial investment in pscychcopharmacological research. The evidence of the further 
involvement of the American government in the testing and marketing of these 
medications is reflected in my analysis on advertisements and their role in the perceptions 
the population has towards the symptoms, etiology, and treatment of affective disorders. 
In addition, Martin (2000) discusses the development of modern American citizens as 
‘mini corporations’ and the parallel cultural desire for accomplishment and personal 
investment. This concept, she suggests, could spark dramatic social change when coupled 
with the dogma that behavior is dictated exclusively by neurological exchange.  
 Martin (2000) also raises awareness of a critical issue- the reductionist ideology 
that reduces human behavior to chemical process is a considerable threat to 
anthropological contributions on the further research of affective disorders.  
“As a discipline, cultural anthropology is threatened by the move to 
neuroreductionism because whole chunks of our sister disciplines… are operating on 
models that ignore the social dimensions of experience. We will not be called on as 
experts in those fields.” 
We cannot permit the exclusion of such vital cultural information in further 
research. It is essential that anthropologists incorporate our skills of ethnographic 
research and the significant qualitative data that is required for a thorough and holistic 
understanding of these disorders. This does not, however, permit us as anthropologists to 
succumb to the same mistake. We cannot disregard the valid contributions that 
neuroscience, psychology, and psychiatry can make to developing additional knowledge 
on a meaningful etiological model.  
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This is precisely why a more applied form of anthropology is essential to 
catalyzing real social change for mental health patients and their families. We must 
maintain our theoretical potency while still utilizing our results to benefit the population 
that is so greatly in need of diversification and alternative perspectives in the mental 
healthcare system. The suggestions made by Barbara Ryklo-Bauer and colleagues (2006) 
call for pragmatic engagement of the discipline into relevant and pressing social issues. 
This desire to educate ourselves and the public has always been a guiding lamp for our 
research goals, but today this lamp must increase with intensity. There is always more 
learn, and there is little concern that the sanctity of academia will be overthrown. Yet 
with the exponential expansion and intermingling of  so many distinct cultures, and the 
dominance of so few, anthropologists must now focus on marrying our theoretical 
foundations with the positive and culturally-informed social change that is essential to 
addressing the societal problems and global conflicts of our time. 
 
CONCLUSIONS AND IMPLICATIONS FOR FURTHER RESEARCH 
This study was constrained by the nature of the project. Given the financial and 
temporal impediments to the use of a larger sample, I chose instead to conduct in-depth, 
one-on-one interviews that were structured more casually to allow for better dialogue and 
a comfortable environment. Participants were encouraged to discuss any details that they 
felt were relevant to their experience, thus forming a more complete narrative of their 
disorder. This resulted in dense and highly informative qualitative data. Acquiring a 
thorough picture for a smaller number of individuals assists in the discovery of intricate 
differences between patients that have a significant impact on the final outcome of their 
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disorders (Kleinman 1989). These intricacies are frequently missed in the massive 
statistical surveys associated with biomedical research, but are critical to the successful 
treatment of mental health conditions (Kirmeyer 2001, Kleinman 1988).  
Despite the limitations upon the scope of this research, my findings indicate the 
need for further investigation into the relationship between family behavioral tendencies, 
thought patterns, parenting methods, and the manifestation of depressive or anxiety 
disorders in children living with a disordered parent. The preliminary results of this study 
suggest there is an association between parents’ openness to discussion of their condition 
and the age of diagnosis and onset of symptoms. Continuing research on this could 
indicate the need for a dialogue with parent and psychiatrist about positive ways to 
explain mental health issues to children, when it is necessary to seek medical attention for 
potential symptoms in children, and discussion of alternative therapies.  
Paramount to the continuation of research on the interaction between culture and 
psychological illness is the application of the knowledge that has already been acquired 
by members of the anthropological, sociological, and psychological communities. The 
authors cited in this analysis are but a few of those who have published extensively on 
this topic. The goal of medical anthropologists continuing this field of study should 
therefore evolve into a harmony of extensive ethnography and practical implementation 
of data collected to the advantage of the population.  
Barbara Ryklo-Bauer and colleagues (2006) argue that it is critical for 
anthropology to maintain relevance in the cultural problems of today, a principle called 
pragmatic engagement. They propose a merger of sorts between theoretical anthropology 
and applied anthropology, where each subfield contributes its strengths to the benefit of 
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the group in need (Ryklo-Bauer et al. 2006). “A meaningful convergence of 
methodologically-sound, critical, reflexive, and engaged anthropology… will free us up 
to focus on differences that actually do matter in the real world… (Ryklo-Bauer et al. 
2006:187). This approach preserves the scientific integrity of the discipline while still 
translating data into observable improvements for those whose needs are revealed 
through thorough ethnographic research, and it is precisely this approach that will 
ultimately result in increased standards of care and a greater range of treatment options 
for depressive and anxiety patients.  
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APPENDIX: Interview Questions 
 
What is your age?  
What culture(s) or ethnicity(ies) do you consider yourself a part of? 
Does anyone in your family suffer from a depressive or anxiety disorder?  
 If yes, have they been diagnosed by a licensed professional? 
 If yes, are they seeking treatment for the condition, and if so, what kind? 
 If yes, how has this affected you personally? 
Do you have any ideas about your family's attitudes or beliefs about mental  
illness?  
  If so, what are they?   
Do you think these beliefs are specific to your family or to other families with a  
similar cultural background that you know of?   
How did the official diagnosis of your condition affect you and your daily life? 
 Did it change your perceptions of yourself?  In what ways?  
 Did it affect the way you interact with those around you?  If so, how?  
Are you seeking treatment of any kind? If so, please describe. 
 How  and why did you choose this treatment option (if you chose it)? 
If someone else made the initial treatment option for you (a relative , for  
example), who was it?   
What role, if any, do other family members have in your treatment decisions?  
 Did you (or your family) consider other options? 
 Are you happy with your choice of treatment? 
 Do you find it to be effective? 
Are you taking a prescription medication for this condition?  
 If yes, what do you know about this medication? 
 What did your doctor tell you about the medication? 
 Did you do any research of your own about the medication? 
 Did your doctor suggest the medication or did you request it? 
 Did you see any advertisements about the medication?  
How do you feel you developed this condition?  
 Do you think genetics are important?  
 Do you ever feel responsible in some way for your condition?  
 Do you feel that others are responsible in any way?  
Do you think that your illness could have been prevented?   
Have you experienced any stigma or preconceptions because of your condition 
among family members?  friends?  People at work?  Others?   
If so, can you give some examples?   
Do you tell other people about your condition?   
Who do you tell or not tell, and why?   
Did you have any preconceived ideas about these conditions prior to your  
diagnosis? 
 If yes, what were they? Have they changed? How so? 
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Do you feel that your ethnic or cultural identity has influenced your experience of 
your illness and its treatment?  
Do you feel that your socioeconomic class or status has affected your experience 
with depression and anxiety, and if so, how?   
 
   
 
 
 
 
